Literature DB >> 23052415

Concomitant antibiotic usage does not augment the risk of inflammatory bowel disease with isotretinoin treatment for acne: a review of the Food and Drug Administration Adverse Event Reporting System.

Derrick J Stobaugh, Parakkal Deepak, Eli D Ehrenpreis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23052415     DOI： 10.1007/s00228-012-1416-1

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  5 in total

1.  Possible association between isotretinoin and inflammatory bowel disease.

Authors:  Deepa Reddy; Corey A Siegel; Bruce E Sands; Sunanda Kane
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

2.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

3.  Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis.

Authors:  Souradet Y Shaw; James F Blanchard; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2011-09-13       Impact factor: 10.864

4.  Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease.

Authors:  David J Margolis; Matthew Fanelli; Ole Hoffstad; James D Lewis
Journal:  Am J Gastroenterol       Date:  2010-08-10       Impact factor: 10.864

5.  Isotretinoin is not associated with inflammatory bowel disease: a population-based case-control study.

Authors:  Charles N Bernstein; Zoann Nugent; Teresa Longobardi; James F Blanchard
Journal:  Am J Gastroenterol       Date:  2009-07-21       Impact factor: 10.864
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.